CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
120 hedge funds and large institutions have $416M invested in Cymabay Therapeutics in 2020 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 29 increasing their positions, 42 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
31% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 42
Holders
120
Holding in Top 10
3
Calls
$3.5M
Puts
$951K
Top Buyers
| 1 | +$36.6M | |
| 2 | +$14.5M | |
| 3 | +$12.9M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$12.5M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$5.95M |
Top Sellers
| 1 | -$12.3M | |
| 2 | -$8.26M | |
| 3 | -$7.65M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.6M |
| 5 |
Citigroup
New York
|
-$6.39M |